PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 455.50
Bid: 453.50
Ask: 455.50
Change: 1.50 (0.33%)
Spread: 2.00 (0.441%)
Open: 459.00
High: 459.00
Low: 448.00
Prev. Close: 454.00
GEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

25 Apr 2023 16:19

RNS Number : 4291X
Genuit Group PLC
25 April 2023
 

Genuit Group plc ('the Company')

Notification of Transactions by Persons Discharging Managerial Responsibilities

The Company announces that on 21 April 2023, an award under the Company's Deferred Share Bonus Plan ("DSBP") was granted over Ordinary Shares of £0.001 each as set out in the table below. The award was made in the form of a nil-cost option which is exercisable for 10 years from the date of grant, unless the exercise period is shortened in accordance with the DSBP rules.

 

 1. Name

 2. No. of Shares subject to DSBP

3. Exercise dates

 4. Lapse Date

Joe Vorih

11,367

21/04/2025 (50%)

21/04/2026 (50%)

21 April 2033

Paul James

6,838

21/04/2025 (50%)

21/04/2026 (50%)

21 April 2033

Matt Pullen

6,836

21/04/2025 (50%)

21/04/2026 (50%)

21 April 2033

 

For further information on the DSBP, please refer to the 2022 Annual Report and Accounts which is available at www.genuitgroup.com

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated. 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Joe Vorih

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer/Director and PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Grant of an award, structured as a nil cost option, under the Company's Deferred Share Bonus Plan, on 21 April 2023, vesting on 21 April 2025 (50%) and 21 April 2026 (50%), exercisable for 10 years from the date of grant.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

11,367

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

21 April 2023

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Paul James

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer/Director and PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Grant of an award, structured as a nil cost option, under the Company's Deferred Share Bonus Plan, on 21 April 2023, vesting on 21 April 2025 (50%) and 21 April 2026 (50%), exercisable for 10 years from the date of grant.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

6,838

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

21 April 2023

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Matt Pullen

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Operating Officer/Director and PDMR

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Genuit Group plc

b)

 

LEI

 

 

2138005IF1N2RKJ6KO18

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of £0.001 each in the capital of Genuit Group plc

 

 

GB00BKRC5K31

 

b)

 

Nature of the transaction

 

 

Grant of an award, structured as a nil cost option, under the Company's Deferred Share Bonus Plan, on 21 April 2023, vesting on 21 April 2025 (50%) and 21 April 2026 (50%), exercisable for 10 years from the date of grant.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil

 

6,836

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A

 

 

 

 

 

e)

 

Date of the transaction

 

 

21 April 2023

f)

 

Place of the transaction

 

 

Outside a Trading Venue

 

Contacts:

Emma Versluys,Group Legal Counsel & Company Secretary

 +44 (0) 1138 315 315

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHNKPBDPBKDOQB
Date   Source Headline
2nd May 20244:57 pmRNSBlock listing Interim Review
24th Apr 202410:39 amRNSNotice of AGM
10th Apr 20244:24 pmRNSDirector/PDMR Shareholding
10th Apr 20244:17 pmRNSDirector/PDMR Shareholding
9th Apr 20244:28 pmRNSDirector Declaration
2nd Apr 20243:56 pmRNSDirector/PDMR Shareholding
20th Mar 20243:27 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFinal Results
1st Mar 20248:30 amRNSDirector Declaration
19th Feb 20249:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20243:49 pmRNSHolding(s) in Company
22nd Nov 20237:00 amRNSStrategy Progress Update Notification
15th Nov 20237:00 amRNSTrading Update
9th Nov 202310:08 amRNSDirector Declaration
2nd Nov 202311:59 amRNSDirector/PDMR Shareholding
1st Nov 20234:00 pmRNSBlock listing Interim Review
1st Nov 20237:00 amRNSDirectorate Change
25th Oct 20234:04 pmRNSDirector/PDMR Shareholding
17th Oct 20234:05 pmRNSDirector/PDMR Shareholding
11th Oct 20233:25 pmRNSDirector/PDMR Shareholding
6th Oct 20233:59 pmRNSDirector/PDMR Shareholding
11th Sep 202312:56 pmRNSDirector/PDMR Shareholding
1st Sep 20239:30 amRNSInterim Chief Financial Officer appointment
23rd Aug 20231:34 pmRNSDirector/PDMR Shareholding
18th Aug 202312:14 pmRNSDirector/PDMR Shareholding
16th Aug 202311:42 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSHalf-year Report
27th Jun 202312:01 pmRNSDirector/PDMR Shareholding
12th Jun 20234:11 pmRNSDirectorate Change
6th Jun 20237:00 amRNSDirectorate Change
18th May 202311:40 amRNSResult of AGM
18th May 20237:00 amRNSTrading Update
2nd May 20239:38 amRNSBlock listing Interim Review
25th Apr 20234:19 pmRNSDirector/PDMR Shareholding
25th Apr 20234:16 pmRNSDirector/PDMR Shareholding
18th Apr 202310:49 amRNSNotice of AGM
13th Apr 20233:57 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
31st Mar 20234:27 pmRNSDirector/PDMR Shareholding
17th Mar 202311:28 amRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
8th Mar 20234:26 pmRNSBoard updates
28th Feb 20235:55 pmRNSHolding(s) in Company
27th Feb 20239:36 amRNSDirectorate Change
31st Jan 202310:22 amRNSDirector Declaration
26th Jan 20236:27 pmRNSHolding(s) in Company
28th Nov 20224:05 pmRNSDirector/PDMR Shareholding
23rd Nov 20227:00 amRNSCapital Markets Day Notification
15th Nov 20228:36 amRNSDirector Declaration
11th Nov 20224:47 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.